These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21522114)

  • 1. Hepatitis C: Impact of ethnicity on hepatitis C treatment outcomes.
    Franks I
    Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(6):299. PubMed ID: 21522114
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.
    Cieply L; Simmons R; Ijaz S; Kara E; Rodger A; Rosenberg W; McGuinness A; Mbisa JL; Ledesma J; Ohemeng-Kumi N; Dicks S; Potts H; Lattimore S; Mandal S
    Epidemiol Infect; 2019 Jan; 147():e145. PubMed ID: 30869036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of ethnicity on hepatitis C virus treatment decisions and outcomes.
    Lisker-Melman M; Walewski JL
    Dig Dis Sci; 2013 Mar; 58(3):621-9. PubMed ID: 23065087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.
    Le AK; Zhao C; Hoang JK; Tran SA; Chang CY; Jin M; Nguyen NH; Yasukawa LA; Zhang JQ; Weber SC; Garcia G; Nguyen MH
    Aliment Pharmacol Ther; 2017 Sep; 46(6):605-616. PubMed ID: 28766727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada.
    Binka M; Butt ZA; McKee G; Darvishian M; Cook D; Wong S; Yu A; Alvarez M; Samji H; Wong J; Krajden M; Janjua NZ
    Int J Infect Dis; 2021 May; 106():246-253. PubMed ID: 33771673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.
    Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L
    Ann Epidemiol; 2016 Aug; 26(8):570-578.e2. PubMed ID: 27480479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Ahn J; Liu B; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence.
    Taylor BC; Yuan JM; Shamliyan TA; Shaukat A; Kane RL; Wilt TJ
    Hepatology; 2009 May; 49(5 Suppl):S85-95. PubMed ID: 19399797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C treatment - better outcomes through partner support.
    Chapman F; McManus A
    Australas Med J; 2012; 5(11):585-8. PubMed ID: 23289048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.
    Latt NL; Alachkar N; Taydas E; Cameron A; Gurakar A
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():45-9. PubMed ID: 24635792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety.
    Latt NL; Yanny BT; Gharibian D; Gevorkyan R; Sahota AK
    World J Gastroenterol; 2017 Jul; 23(26):4759-4766. PubMed ID: 28765697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia.
    Jeong D; Karim ME; Wong S; Wilton J; Butt ZA; Binka M; Adu PA; Bartlett S; Pearce M; Clementi E; Yu A; Alvarez M; Samji H; Velásquez García HA; Abdia Y; Krajden M; Janjua NZ
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34099439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcome in patients with hepatitis C virus genotype 4.
    Kamal SM
    Am J Gastroenterol; 2007 Nov; 102(11):2582-8. PubMed ID: 17900328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective.
    Nkuize M; Sersté T; Buset M; Mulkay JP
    Ther Clin Risk Manag; 2016; 12():861-72. PubMed ID: 27350749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity.
    Lam KD; Bacchetti P; Abbasi F; Ayala CE; Loeb SM; Shah V; Wen MJ; Reaven GM; Maher JJ; Khalili M
    Hepatology; 2010 Jul; 52(1):38-46. PubMed ID: 20578127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessing provider reporting in the age of electronic surveillance.
    Stachel AG; Waechter H; Bornschlegel K; Reddy V; Hanson H; Wen T; Baumgartner J; Balter S
    J Public Health Manag Pract; 2014; 20(2):240-5. PubMed ID: 24458313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America.
    Scott-Wright A; Hakre S; Bryan JP; Jaramillo R; Reyes LG; Cruess D; Macarthy PO; Gaydos JC
    Am J Trop Med Hyg; 1997 Mar; 56(3):285-90. PubMed ID: 9129530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.
    Bell SJ; Lau A; Thompson A; Watson KJ; Demediuk B; Shaw G; Chen RY; Ayres A; Yuen L; Bartholomeusz A; Locarnini SA; Desmond PV
    J Clin Virol; 2005 Feb; 32(2):122-7. PubMed ID: 15653414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment.
    Harrison SA
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):864-76. PubMed ID: 18585970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.